Sponsor Pipeline

Qingxia Li Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07139587 The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With… Gastric Cancer Not Yet Recruiting
Disease Areas
Gastric Cancer (1)
Get alerts when Qingxia Li's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free